Page last updated: 2024-08-17

bromodeoxyuridine and Dementia

bromodeoxyuridine has been researched along with Dementia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Li, L; Lu, Z; Qi, J; Zhou, L	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Dementia

Article	Year
Pro-neurogenesis and anti-dementia properties of tetradecyl 2,3-dihydroxybenzoate through TrkA receptor-mediated signalling pathways. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:11 Topics: Amyloid beta-Peptides; Animals; Bromodeoxyuridine; Dementia; Disease Models, Animal; Doublecortin Domain Proteins; Glial Fibrillary Acidic Protein; Hippocampus; Hydroxybenzoates; Male; MAP Kinase Signaling System; Maze Learning; Memory; Mice; Mice, Inbred ICR; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Peptide Fragments; Phosphopyruvate Hydratase; Receptor, trkA; RNA, Messenger; Time Factors; TOR Serine-Threonine Kinases	2014

Article

Year

Pro-neurogenesis and anti-dementia properties of tetradecyl 2,3-dihydroxybenzoate through TrkA receptor-mediated signalling pathways.

The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:11

Topics: Amyloid beta-Peptides; Animals; Bromodeoxyuridine; Dementia; Disease Models, Animal; Doublecortin Domain Proteins; Glial Fibrillary Acidic Protein; Hippocampus; Hydroxybenzoates; Male; MAP Kinase Signaling System; Maze Learning; Memory; Mice; Mice, Inbred ICR; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Peptide Fragments; Phosphopyruvate Hydratase; Receptor, trkA; RNA, Messenger; Time Factors; TOR Serine-Threonine Kinases

2014